Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![ArkadiBaudelair Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1832110302701166592.png) Arkadi [@ArkadiBaudelair](/creator/twitter/ArkadiBaudelair) on x 1405 followers
Created: 2025-07-15 22:23:09 UTC

6.Transparency

The company clearly outlined its clinical timelines, planning to start trials for Wilson’s Disease in the first half of 2026 and for AATD by mid 2026. 

This roadmap provides us investors with clear upcoming catalysts and milestones to track progress.


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945247791480979626/c:line.svg)

[Post Link](https://x.com/ArkadiBaudelair/status/1945247791480979626)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

ArkadiBaudelair Avatar Arkadi @ArkadiBaudelair on x 1405 followers Created: 2025-07-15 22:23:09 UTC

6.Transparency

The company clearly outlined its clinical timelines, planning to start trials for Wilson’s Disease in the first half of 2026 and for AATD by mid 2026.

This roadmap provides us investors with clear upcoming catalysts and milestones to track progress.

XXX engagements

Engagements Line Chart

Post Link

post/tweet::1945247791480979626
/post/tweet::1945247791480979626